Incidence of type 2 diabetes in the randomized multiple risk factor intervention trial

George Davey Smith1, Yiscah Bracha, Kenneth H Svendsen

  • 1Department of Social Medicine, University of Bristol, Bristol, United Kingdom. zetkin@bristol.ac.uk

Abstract

Insights

A lifestyle intervention reduced diabetes risk in non-smokers without impaired glucose tolerance. However, the intervention did not significantly impact diabetes risk in smokers, possibly due to weight gain post-cessation.

Area of Science:

  • Cardiovascular Disease Prevention
  • Metabolic Health
  • Clinical Trials

Background:

  • Lifestyle interventions like weight loss and exercise are known to reduce diabetes risk in individuals with impaired glucose tolerance.
  • Evidence regarding the impact of these interventions on individuals without impaired glucose tolerance is limited.
  • This study investigates a comprehensive intervention program's effect on diabetes risk in men without pre-existing glucose intolerance.

Purpose of the Study:

  • To assess the efficacy of a comprehensive lifestyle intervention in preventing diabetes development among men without impaired glucose tolerance.
  • To conduct a subgroup analysis examining the intervention's effect based on baseline cigarette smoking status.

Main Methods:

  • A randomized controlled trial involving 11,827 men without diabetes or impaired glucose tolerance.
  • Participants were assigned to either a special intervention group or a usual care group.
  • Intervention included dietary counseling, smoking cessation support, increased physical activity, and intensive blood pressure management.

Main Results:

  • Over 6 years, 11.5% in the intervention group and 10.8% in the usual care group developed diabetes.
  • The intervention significantly reduced diabetes risk in non-smokers (hazard ratio 0.82).
  • In smokers, the intervention showed no significant benefit (hazard ratio 1.26), with potential counterbalancing factors like weight gain post-smoking cessation.

Conclusions:

  • A comprehensive lifestyle intervention program effectively reduced diabetes risk in non-smoking men without impaired glucose tolerance.
  • The intervention's benefits were not observed in smokers, suggesting other factors may influence diabetes development in this group.
  • Further research is needed to understand the complex interplay of lifestyle, smoking cessation, and diabetes risk.

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.5K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.0K
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
121
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
57
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
36
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated...
32